Health Chinese Biopharma Sector Surges with Record Licensing Deals The Chinese biopharmaceutical sector has experienced a remarkable turnaround, entering 2026 with significant momentum. In 2025, the value of outbound licensing and drug development... Editorial8 January, 2026